GB202215576D0 - Circuit - Google Patents

Circuit

Info

Publication number
GB202215576D0
GB202215576D0 GBGB2215576.6A GB202215576A GB202215576D0 GB 202215576 D0 GB202215576 D0 GB 202215576D0 GB 202215576 A GB202215576 A GB 202215576A GB 202215576 D0 GB202215576 D0 GB 202215576D0
Authority
GB
United Kingdom
Prior art keywords
circuit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2215576.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prokarium Ltd
Original Assignee
Prokarium Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prokarium Ltd filed Critical Prokarium Ltd
Priority to GBGB2215576.6A priority Critical patent/GB202215576D0/en
Publication of GB202215576D0 publication Critical patent/GB202215576D0/en
Priority to PCT/EP2023/079317 priority patent/WO2024084054A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB2215576.6A 2022-10-21 2022-10-21 Circuit Ceased GB202215576D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2215576.6A GB202215576D0 (en) 2022-10-21 2022-10-21 Circuit
PCT/EP2023/079317 WO2024084054A1 (en) 2022-10-21 2023-10-20 Modified microorganisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2215576.6A GB202215576D0 (en) 2022-10-21 2022-10-21 Circuit

Publications (1)

Publication Number Publication Date
GB202215576D0 true GB202215576D0 (en) 2022-12-07

Family

ID=84818612

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2215576.6A Ceased GB202215576D0 (en) 2022-10-21 2022-10-21 Circuit

Country Status (2)

Country Link
GB (1) GB202215576D0 (en)
WO (1) WO2024084054A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (en) 1982-10-18 1982-10-18 Bror Morein IMMUNOGENT MEMBRANE PROTEIN COMPLEX, SET FOR PREPARATION AND USE THEREOF
SE8405493D0 (en) 1984-11-01 1984-11-01 Bror Morein IMMUNOGENT COMPLEX AND KITCHEN FOR PREPARING IT AND USING IT AS IMMUNOSTIMENTING AGENTS
DK166762B1 (en) 1986-01-14 1993-07-12 Nederlanden Staat PROCEDURE FOR PREPARING IMMUNOGENIC COMPLEXES AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPLEXES
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
EP2801364A1 (en) 2013-05-07 2014-11-12 Centre Hospitalier Universitaire Vaudois (CHUV) Salmonella strain for use in the treatment and/or prevention of cancer
US10806778B2 (en) 2019-01-30 2020-10-20 Prokarium Limited Modified strain of Salmonella enterica Typhi
WO2022034221A1 (en) * 2020-08-14 2022-02-17 Julius-Maximilians-Universität Würzburg Salmonella vaccine for the treatment of coronavirus
CA3195544A1 (en) * 2020-10-27 2022-05-05 T3 Pharmaceuticals Ag Bacteria based protein delivery

Also Published As

Publication number Publication date
WO2024084054A1 (en) 2024-04-25

Similar Documents

Publication Publication Date Title
CA205121S (en) Circuit board
EP4111834A4 (en) Circuit structure
GB2589410B (en) Circuit board assembly
CA205122S (en) Circuit board
GB201903018D0 (en) Circuit breaker
CA195757S (en) Circuit board
GB2601215B (en) Circuit
GB201917294D0 (en) Electrical circuit design
EP4009752A4 (en) Circuit board
GB202215576D0 (en) Circuit
GB201917295D0 (en) Electrical circuit design
EP3927123A4 (en) Circuit board
GB202314405D0 (en) Integrated circuit
CA205120S (en) Circuit board
CA205119S (en) Circuit board
CA213827S (en) Circuit board
CA197994S (en) Circuit board
GB202203061D0 (en) Interface circuit portions
GB2615426B (en) High frequency circuit
GB202106220D0 (en) Ramp circuit
GB202316637D0 (en) Stand-by circuit
GB202313267D0 (en) Circuit communication
GB202406305D0 (en) Dimmer circuit improvement
GB202002692D0 (en) Flexible circuit Rogowskis
GB201917293D0 (en) Electrical circuit design

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)